The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2019 | The Manchester Lung Health Check Pilot: integrating biomarkers into screening
The Manchester Lung Health Check Pilot has taken screening into the community, where many are at high-risk of lung cancer, as discussed here by Philip Crosbie, MBChB, MRCP, PhD, of the University of Manchester, Manchester, UK. Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, Dr Crosbie highlights how blood samples in the second round were used for biomarker screening, which has provided a model for patient selection for screening.
